Maartje I. Kester

Learn More
Evaluation of plasma A 40 and A 42 as predictors of conversion to Alzheimer’s disease in patients with mild cognitive impairment Maartje I. Kester a,∗, Nicolaas A. Verwey a,b, Evert J. van Elk b,(More)
BACKGROUND Multiplex assays such as xMAP have been proposed for the assessment of Alzheimer's disease (AD) biomarkers amyloid β 42 (Aβ42), tau (Tau), and phosphorylated tau (pTau) in cerebrospinal(More)